Date of Initial Handover meeting: 8 June 2023
Date of Final Handover meeting: 13 June 2023
Attendees
- Andrew Atkinson (AAT) - on leave for meeting 8 June
- Maria Braithwaite (MBR)
- Donna Morgan (DMO)
- Chris Morris(CMA)
- Joe Schofield(JSC)
Page properties | ||
---|---|---|
|
Agenda
Items to be discussed | Actions | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Prerelease Content Management Activities:
|
| ||||||||||||||||
2 | Discussion of existing Known Issues from the previous Release |
| ||||||||||||||||
3 | Content Validation
|
https://jira.ihtsdotools.org/browse/INFRA-10919 https://jira.ihtsdotools.org/browse/INFRA-10920 https://jira.ihtsdotools.org/browse/ATF-1680 https://jira.ihtsdotools.org/browse/ATF-1679 Changes checked and confirmed with Yong 22 May 2023 https://docs.google.com/spreadsheets/d/1kQmRTCYrWkN9iaZkiFAJfJiALdYpe8iP-hWm_moNnnI/edit?usp=sharing | ||||||||||||||||
4 | Mapping schedule | January 2023:
February 2023:
March 2023:
April 2023:
May 2023:
***** NOTE: Make sure we keep an eye on the upgrade to ICD-0 version 3.2/3.4/4.0, as it "MAY" happen at some point in 2023 (though unlikely now) *****
| ||||||||||||||||
5 | Brief run through of the known issues already identified by the content team during the QA batch process, to ensure that technical team are aware of them, and can either resolve them in time for the release, or confirm as known issues. | Unable to run Pre release content validation report
Daily build validation failures
| ||||||||||||||||
6 | DevOps resource confirmed | |||||||||||||||||
7 | Versioning and Change Freeze | Plan is to follow the new processes as now defined: AAT walked through and agreed new process with DevOps already, so unless there are any further questions/issues?? HIGH LEVEL KEY MILESTONES:
| ||||||||||||||||
8 | Stats Report | Reports run via the reporting platform: Summary Component stats for edition 7 June 2023 https://docs.google.com/spreadsheets/d/1qs97hrRgdW5vOxfuLqEblNtoHbU8Wesu4ktJ4xRuxdc/edit#gid=0 | ||||||||||||||||
9 | Risks | |||||||||||||||||
10 | AOB |
|